Introduction
Obesity is reaching epidemic proportions worldwide. It occurs when the balance of energy intake and energy expenditure is disrupted over a period of time and thus leading to high adipose tissue accretion. Research is focusing on preventative and therapeutic methods to alleviate the problem.
Pantothenic acid (PA) has become of interest due to research showing its' and its derivatives lipid-mediating effects. Previous work at our research station demonstrated that PA additions in amounts greater than that needed to maximize BW gain resulted in linear reductions in subcutaneous carcass fat depth and increases in the carcass lean (fat-free) tissue content of growing pigs. Overall, the subjects in the above studies consumed low fat, high starch diets ad libitum, thus de novo lipogenesis (DNL) would be expected to play a large role in body fat accretion. In contrast, Americans typically consume a diet that is high in fat, which would limit the role of DNL relative to direct fat deposition in body fat accretion.
The objective of the current study was to determine the efficacy of dietary PA as a modifier of body composition in a porcine model of obesity development induced by a high fat dietary regimen.
Materials and Methods
Experimental treatments consisted of a basal diet supplemented with four levels of pantothenic acid (0, 80, 800, 8000 ppm) added as d-calcium pantothenate. The basal diet contained 8 ppm of PA that met or exceeded the current estimated needs of pigs and humans. The 80 ppm PA addition closely represented the amounts per unit of estimated body energy expenditure that have been shown to effectively reduce body fat accretion and increase body lean accretion in growing pigs consuming a high starch diet ad libitum. The basal diet was formulated to provide a calorie mix representative of that typically consumed by adults in the US and to provide nutrient intakes that met or exceeded the animal's needs for body maintenance and expected tissue growth. The calorie sources in the diet, expressed as % of total calories, were 33 % fat, 17 % protein and 9 % fiber.
Pigs were provided daily dietary caloric intakes equivalent to 1.8 times their estimated body maintenance (110 kcal ME/ BW kg .75 / day) needs based on the weekly mean BW of each animal. Their daily feed allocation was divided equally into 0700 and 1600 hr feedings. Pigs were penned individually and fed their respective diets from 156 to 240 kg BW. Seventeen barrows from a high lean strain were evaluated per dietary treatment. Pigs were randomly allotted to dietary treatment by BW and date on test (block).
After 144 d, pigs were transported to the abattoir, electrically stunned and killed by exsanguination. Two tissue depots (carcass and internal organs with associated fat tissues) were isolated, weighed and subsequently scanned by dual-energy x-ray absorptiometry for determination of body tissue content. Subcutaneous fat depth at the midline of each carcass also was measured at the first rib, last rib, last lumbar vertebrae. Liver samples from representative pigs in the 0 and 8000 ppm treatments were evaluated for acetyl-CoA carboxylase, acyl-CoA oxidase, and fatty acid synthetase (all major enzymes in fat metabolism) mRNA expression by real-time PCR.
For estimation of the pig's initial body composition, thirteen pigs representative of the starting weights of the pigs on test were sacrificed and the composition of the body depots were determined using the same procedures as above.
Results and Discussion
A state of obesity development occurred over the duration of the study. Animals accrued 72.85 kg BW consisting of 67.49 kg of carcass and 5.36 kg of organ tissues. Total body fat accretion was 34.88 kg and represented 48 % of the accrued body weight. Of the accrued body fat, 32.3 kg or 93 % was deposited in the whole carcass depot and 2.58 kg or 7 % were accrued in the organ depot. Although the proportion of BW gain accrued as fat was 48 % compared with 27 % fat tissue present prior to the initiation of the study, the proportional distribution of body fat among the carcass and organ depots remained the same.
As expected, PA additions did not alter daily body weight gain, feed intake, or the efficiency of feed utilization in pigs growing from 156 to 240 kg BW. Cold carcass weights and subcutaneous backfat depths did not differ among PA treatment groups. Gastrointestinal tract and left kidney weights increased linearly as dietary PA additions increased (P< .13). Longissimus muscle area at the tenth rib decreased quadratically as PA additions increased (P= .01).
Carcass fat tissue content, expressed as kg of tissue (P= .10) or % of carcass weight (P= .14), responded quadratically as dietary PA additions increased. Carcass fat was lowered by .9 percentage units with the incremental addition of 80 ppm PA and increased by 1.8 and 1.0 percentage units by the additions of 800 and 8000 ppm PA. Organ fat tissue as well as total organ weights increased quadratically (P< .03) as PA additions increased. Organ fat content, expressed as a % of organ weight, was numerically lowered by .6 percentage units with the 80 ppm PA addition and increased by .7 and 2.7 percentage units by the 800 and 8000 ppm PA additions.
These shifts in organ fat content were largely due to changes in the fat content of the gastrointestinal tract depot. Whole body fat tissue increased quadratically (P< .09) as dietary PA additions increased. Whole body fat percentages were shifted by -.8, +1.6 and +1.1 percentage units with the addition of 80, 800 and 8000 ppm PA, respectively.
In the current obesity development study, body fat tissue contents were reduced by a smaller magnitude and less consistently with a ten fold increase in PA than that observed in pigs with a high capability for de novo fat synthesis induced by high carbohydrate feeding. The lower response in the current study is hypothesized to be due in part to a low rate of de novo fat synthesis (DNL) occurring relative to direct deposition of ingested fat. The high fat diet also probably limited the ability to see a difference in mRNA expression of the fat metabolism enzymes between the 0 and 8000 ppm PA treatments due to the enzyme's assistance in DNL. The liver in pigs also may not contribute much to fat accretion through DNL, which occurs mainly in the adipose tissue.
In conclusion, a porcine model of obesity development was effectively created by feeding a high dietary fat regimen at 1.8 times body maintenance needs. Dietary PA additions in this model resulted in quadratic responses in fat tissue content in carcass and organ depots but did not affect hepatic fat metabolism enzyme gene expression. A ten fold increase in PA intake above that needed to maximize BW gain resulted in small reductions in body fat content; whereas, 100 and 1000 fold increases in PA intake resulted in increases in body (carcass and organ depots) fat content. 
